MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00432-026-06493-x

Медицинская библиотека · Journal of cancer research and clinical oncology · 2026

Diagnostic performance of the NI-RADS system for detecting recurrence in head and neck squamous cell carcinoma: a monocentric pilot study.

Greco Sara, Villanova Ilaria, Maggialetti Nicola, Lorusso Giovanni, Lucarelli Nicola Maria, Morelli Chiara, Dipalma Claudia, Brunese Maria Chiara, Copelli Chiara, Ianora Amato Antonio Stabile

СтатьяПеревод в очереди

Аннотация

BACKGROUND

This pilot study evaluates the diagnostic performance and clinical relevance of the Neck Imaging Reporting and Data System (NI-RADS) in the post-treatment surveillance of patients with head and neck squamous cell carcinoma (HNSCC), using computed tomography (CT) and magnetic resonance imaging (MRI).

METHODS

This retrospective study included 25 patients with histologically confirmed HNSCC treated between August 2021 and December 2024. All patients underwent at least two post-treatment CT or MRI scans, independently reviewed by two radiologists and classified according to the NI-RADS system. Recurrence was confirmed by histopathology or clinical and imaging follow-up. Diagnostic performance metrics, including sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy, were calculated using a threshold of NI-RADS ≥ 3. Receiver operating characteristic (ROC) analysis was performed for primary and neck sites.

RESULTS

A total of 56 imaging studies and 112 anatomical sites were assessed. Recurrence was confirmed in 36% of primary sites and 27% of neck sites. NI-RADS category 1 showed 0% recurrence, whereas category 4 showed 100% recurrence for both anatomical sites. For the primary site, sensitivity was 80% (95% CI: 56-94%) and specificity 92% (95% CI: 78-98%), with an accuracy of 88% (95% CI: 76-95%). For neck sites, sensitivity was 80% (95% CI: 52-96%) and specificity 98% (95% CI: 87-100%), with an accuracy of 93% (95% CI: 82-98%). The area under the ROC curve was 0.86 for the primary site and 0.88 for the neck site.

CONCLUSIONS

NI-RADS showed good diagnostic performance for detecting locoregional recurrence in post-treatment surveillance of HNSCC using CT and MRI. However, given the retrospective design and limited sample size, these findings should be considered preliminary and require confirmation in larger prospective studies.

Для цитирования: Greco Sara, Villanova Ilaria, Maggialetti Nicola, Lorusso Giovanni, Lucarelli Nicola Maria, Morelli Chiara, Dipalma Claudia, Brunese Maria Chiara, Copelli Chiara, Ianora Amato Antonio Stabile. Diagnostic performance of the NI-RADS system for detecting recurrence in head and neck squamous cell carcinoma: a monocentric pilot study.. Journal of cancer research and clinical oncology. 2026. DOI: 10.1007/s00432-026-06493-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.